Neuroimmunology
Anti-NMDA receptor encephalitis
Aug. 07, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Professor of Neurology
Hospital Clinic/IDIBAPS and La CaixaResearch Institute
University of Barcelona, Spain
Adjunct Professor of Neurology
University of Pennsylvania
In July 2023, Dr Josep Dalmau received the Camillo Golgi Award from the European Academy of Neurology in recognition of his research into autoimmune encephalitis.
In May 2023, Dr Dalmau received the Scientific Breakthrough 2023 Award from the American Brain Foundation in recognition of his commitment to enriching our understanding of autoimmune neurological diseases such as encephalitis, paraneoplastic syndromes, and others over the course of his career.
Dr. Dalmau of IDIBAPS, University of Barcelona, receives royalties from Euroimmun for intellectual property rights and contracted research funds from Euroimmun as a principal investigator, has received consulting fees from Astellas Research Institute of America and Janssen Research & Development, and has received research funding from Sage Therapeutics.